Centura Health Neurosciences and Spine, Lakewood, Colorado, USA.
University of Utah Health Sciences Center, Salt Lake City, Utah, USA.
J Neurointerv Surg. 2019 Feb;11(2):127-132. doi: 10.1136/neurintsurg-2018-013873. Epub 2018 Jun 21.
Stent retriever thrombectomy (SRT) in acute thromboembolic stroke can result in post-thrombectomy subarachnoid hemorrhage (PTSAH). Intraprocedural findings associated with PTSAH are not well defined.
To identify angiographic findings and procedural factors during SRT that are associated with PTSAH.
This was a retrospective, observational cohort study of consecutive patients with middle cerebral artery (MCA) acute ischemic stroke treated with SRT. Inclusion criteria were: (1) age ≥18 years; (2) thromboembolic occlusion of the MCA; (3) at least one stent retriever pass beginning in an M2 branch; (4) postprocedural CT or MRI scan within 24 hours; (5) non-enhanced CT Alberta Stroke Program Early CT Score >5. Exclusion criteria included multi-territory stroke before SRT.
Eighty-five patients were enrolled; eight patients had PTSAH (group 1) and 77 did not (group 2). Baseline demographic and clinical characteristics were comparable between the two groups. In group 1, a significantly greater proportion of patients had more than two stent retriever passes (62.5% vs 18.2%, P=0.01), a stent retriever positioned ≥2 cm along an M2 branch (100% vs 30.2%, P=0.002), and the presence of severe iatrogenic vasospasm before SRT pass (37.5% vs 5.2%, P=0.02). One patient with PTSAH and associated mass effect deteriorated clinically.
An increased number of stent retriever passes, distal device positioning, and presence of severe vasospasm were associated with PTSAH. Neurological deterioration with PTSAH can occur.
急性血栓栓塞性脑卒中的支架取栓术(SRT)可导致取栓术后蛛网膜下腔出血(PTSAH)。与 PTSAH 相关的术中发现尚不清楚。
确定 SRT 过程中与 PTSAH 相关的血管造影发现和程序因素。
这是一项连续对接受 SRT 治疗的大脑中动脉(MCA)急性缺血性脑卒中患者进行的回顾性观察队列研究。纳入标准为:(1)年龄≥18 岁;(2)MCA 血栓栓塞性闭塞;(3)至少进行一次起始于 M2 分支的支架取栓器通过;(4)术后 24 小时内行 CT 或 MRI 扫描;(5)非增强 CT 阿尔伯塔卒中项目早期 CT 评分>5。排除标准包括 SRT 前多部位卒中。
共纳入 85 例患者,其中 8 例发生 PTSAH(组 1),77 例未发生(组 2)。两组患者的基线人口统计学和临床特征无差异。组 1 患者支架取栓器通过次数(62.5%比 18.2%,P=0.01)、支架取栓器在 M2 分支的位置(100%比 30.2%,P=0.002)和 SRT 前存在严重医源性血管痉挛的比例(37.5%比 5.2%,P=0.02)均显著更高。1 例 PTSAH 合并占位效应的患者临床恶化。
支架取栓器通过次数增加、远端器械位置和严重血管痉挛与 PTSAH 相关。PTSAH 可导致神经功能恶化。